Dr. Ashley Ghiaseddin, MD
Claim this profileUF Health
Studies Glioblastoma
Studies Relapse
7 reported clinical trials
11 drugs studied
Area of expertise
1Glioblastoma
MET negative
MET positive
CD70 positive
2Relapse
IDH positive
1p/19q co-deletion positive
Affiliated Hospitals
Clinical Trials Ashley Ghiaseddin, MD is currently running
CAR T Cell Therapy
for Glioblastoma
This trial tests a new treatment where a patient's own immune cells are modified to better attack brain cancer cells. It targets adults with a specific type of brain cancer (glioblastoma) that shows a certain marker (CD70). The modified cells are designed to recognize and kill the cancer more effectively. CD70 is a protein that is usually limited in normal tissue but appears in various cancers.
Recruiting1 award Phase 1
Cellular Therapy
for Brain Tumors
This study will enroll 6 DLT evaluable subjects (up to 12 patients total) where we will evaluate feasibility and safety of adoptive cellular therapy combined with IDH1/2 inhibitors in patients with recurrent or progressive oligodendroglioma WHO grade 2 and WHO grade 3.
Recruiting1 award Phase 1
More about Ashley Ghiaseddin, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Ashley Ghiaseddin, MD has experience with
- Pembrolizumab
- NeuroBlate®
- RNA-Lipid Particle (RNA-LP) Vaccines
- Optune System
- Temozolomide
- Autologous Hematopoietic Stem Cells (HSCs)
Breakdown of trials Ashley Ghiaseddin, MD has run
Glioblastoma
Relapse
Oligodendroglioma-Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ashley Ghiaseddin, MD specialize in?
Ashley Ghiaseddin, MD focuses on Glioblastoma and Relapse. In particular, much of their work with Glioblastoma has involved MET negative patients, or patients who are MET positive.
Is Ashley Ghiaseddin, MD currently recruiting for clinical trials?
Yes, Ashley Ghiaseddin, MD is currently recruiting for 5 clinical trials in Gainesville Florida. If you're interested in participating, you should apply.
Are there any treatments that Ashley Ghiaseddin, MD has studied deeply?
Yes, Ashley Ghiaseddin, MD has studied treatments such as Pembrolizumab, NeuroBlate®, RNA-Lipid Particle (RNA-LP) Vaccines.
What is the best way to schedule an appointment with Ashley Ghiaseddin, MD?
Apply for one of the trials that Ashley Ghiaseddin, MD is conducting.
What is the office address of Ashley Ghiaseddin, MD?
The office of Ashley Ghiaseddin, MD is located at: UF Health, Gainesville, Florida 32610 United States. This is the address for their practice at the UF Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.